1: Chen B, Shi HQ, Feng MR, Wang XH, Cao XM, Cai WM. Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population. Front Pharmacol. 2022 Jul 19;13:932686. doi: 10.3389/fphar.2022.932686. 2: Amlabu V, Mulligan C, Jele N, Evans A, Gray D, Zar HJ, McIlleron H, Smith P. Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children. Int J Tuberc Lung Dis. 2014 May;18(5):528-30. doi: 10.5588/ijtld.13.0730. 3: Sharma S, Anand A, Verma N, Sharma V, Bhatia A, Patil AN, Banerjee D. Pharmacokinetic Assessment of Isoniazid and Acetylisoniazid in Carbon Tetrachloride-Induced Liver Injury Model in Wistar Rats. J Pharm Bioallied Sci. 2023 Jul-Sep;15(3):139-145. doi: 10.4103/jpbs.jpbs_320_23. Epub 2023 Aug 15.
合成参考文献
摘要:Liu P, Jiang JM, Zhou ZF. [High-performance liquid chromatography for detecting the concentrations of isoniazid and acetylisoniazid in spinal tuberculosis]. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Feb;30(2):364–7.